Zhanguo Zhang

3.1k total citations · 1 hit paper
76 papers, 2.0k citations indexed

About

Zhanguo Zhang is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Zhanguo Zhang has authored 76 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 18 papers in Oncology and 16 papers in Hepatology. Recurrent topics in Zhanguo Zhang's work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Liver Disease Diagnosis and Treatment (10 papers) and Pancreatic and Hepatic Oncology Research (9 papers). Zhanguo Zhang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Liver Disease Diagnosis and Treatment (10 papers) and Pancreatic and Hepatic Oncology Research (9 papers). Zhanguo Zhang collaborates with scholars based in China, United States and Japan. Zhanguo Zhang's co-authors include Bixiang Zhang, Furong Liu, Wanguang Zhang, Xin Long, Xiaoping Chen, Huifang Liang, Zhibin Liao, Xiaoping Chen, Jia Song and Weixun Chen and has published in prestigious journals such as Cell, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Zhanguo Zhang

73 papers receiving 1.9k citations

Hit Papers

ACE2 Expression in Pancreas May Cause Pancreatic Damage A... 2020 2026 2022 2024 2020 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhanguo Zhang China 22 773 455 431 426 326 76 2.0k
Hongbo Wang China 22 765 1.0× 446 1.0× 283 0.7× 301 0.7× 121 0.4× 99 1.8k
Katja Evert Germany 19 433 0.6× 168 0.4× 109 0.3× 177 0.4× 161 0.5× 79 1.3k
Masaaki Takamura Japan 28 870 1.1× 332 0.7× 55 0.1× 542 1.3× 300 0.9× 100 2.2k
Salvatore Pisconti Italy 22 502 0.6× 396 0.9× 68 0.2× 692 1.6× 208 0.6× 97 1.7k
Shuangfeng Chen China 15 308 0.4× 156 0.3× 110 0.3× 175 0.4× 90 0.3× 56 833
Ngan‐Ming Tsang Taiwan 31 459 0.6× 279 0.6× 68 0.2× 955 2.2× 748 2.3× 88 2.3k
Jae Ho Han South Korea 28 448 0.6× 146 0.3× 57 0.1× 509 1.2× 402 1.2× 88 1.5k
George Haddad Canada 25 1.0k 1.3× 372 0.8× 109 0.3× 925 2.2× 450 1.4× 51 2.4k
Matthias Ilmer Germany 20 837 1.1× 341 0.7× 41 0.1× 667 1.6× 202 0.6× 68 1.7k

Countries citing papers authored by Zhanguo Zhang

Since Specialization
Citations

This map shows the geographic impact of Zhanguo Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhanguo Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhanguo Zhang more than expected).

Fields of papers citing papers by Zhanguo Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhanguo Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhanguo Zhang. The network helps show where Zhanguo Zhang may publish in the future.

Co-authorship network of co-authors of Zhanguo Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhanguo Zhang. A scholar is included among the top collaborators of Zhanguo Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhanguo Zhang. Zhanguo Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Mengmeng, Furong Liu, Ming Jiang, et al.. (2025). Bioinspired Dual‐Ionic‐Site Single‐Atom Nanozymes for Synergistic Ferroptosis/Cuproptosis and Enhanced Immune Checkpoint Blockade Therapy. Small. 21(35). e2501076–e2501076. 4 indexed citations
2.
Liu, Furong, Ze Zhang, Ze Zhang, et al.. (2025). Hafnium Metal–Organic Framework-Based Glutamine Metabolism Disruptor For Potentiating Radio-Immunotherapy in MYC-Amplified Hepatocellular Carcinoma. ACS Applied Materials & Interfaces. 17(13). 19367–19381. 1 indexed citations
3.
4.
Chen, Su, Zhibin Liao, Furong Liu, et al.. (2025). VRK2 targeting potentiates anti-PD-1 immunotherapy in hepatocellular carcinoma through MYC destabilization. Nature Communications. 16(1). 9027–9027.
7.
Li, Jin, Yusheng Zhang, Lijun Zhang, Guoqing Wang, & Zhanguo Zhang. (2024). Methane dehydroaromatization over Mo/H-ZSM-5: A comparative study of the regeneration methods. Applied Catalysis A General. 679. 119732–119732. 7 indexed citations
8.
Zhu, Yongxia, Baofang Jin, Jiajian Gao, et al.. (2023). Structural evolution of the CuO catalyst modified with ZnO, Sn, and P promoters in the Rochow-Müller reaction. Journal of Catalysis. 429. 115262–115262. 2 indexed citations
9.
Xiong, Yixiao, Xiaochao Zhang, Jinghan Zhu, et al.. (2023). Collagen I-DDR1 signaling promotes hepatocellular carcinoma cell stemness via Hippo signaling repression. Cell Death and Differentiation. 30(7). 1648–1665. 35 indexed citations
10.
Liu, Furong, Zhibin Liao, Qin Lu, et al.. (2023). Targeting VPS72 inhibits ACTL6A/MYC axis activity in HCC progression. Hepatology. 78(5). 1384–1401. 13 indexed citations
11.
Zhang, Qiaofeng, Furong Liu, Qin Lu, et al.. (2021). Characterization of TGFβ-associated molecular features and drug responses in gastrointestinal adenocarcinoma. BMC Gastroenterology. 21(1). 284–284. 5 indexed citations
12.
Zhang, Xinzhuang, et al.. (2021). Study on attrition of spherical-shaped Mo/HZSM-5 catalyst for methane dehydro-aromatization in a gas–solid fluidized bed. Chinese Journal of Chemical Engineering. 38. 172–183. 7 indexed citations
13.
Zhang, Haowen, et al.. (2021). Morphine Suppresses Liver Cancer Cell Tumor Properties In Vitro and In Vivo. Frontiers in Oncology. 11. 666446–666446. 14 indexed citations
14.
15.
Liu, Furong, Xin Long, Bixiang Zhang, et al.. (2020). ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection. Clinical Gastroenterology and Hepatology. 18(9). 2128–2130.e2. 462 indexed citations breakdown →
16.
Zhang, Yuxin, Jianping Zhao, Songshan Chai, et al.. (2019). Reliable reconstruction of the complex high-location bile duct injury: a novel hepaticojejunostomy. BMC Surgery. 19(1). 176–176. 2 indexed citations
17.
Wu, Jingjing, Zhanguo Zhang, Peng Zhu, et al.. (2019). Comparative liver function models for ruptured hepatocellular carcinoma: A 10-year single center experience. Asian Journal of Surgery. 42(9). 874–882. 11 indexed citations
18.
Yan, Peng, Zhanguo Zhang, Dapeng Li, et al.. (2018). Development of a CH4 dehydroaromatization–catalyst regeneration fluidized bed system. Chinese Journal of Chemical Engineering. 26(9). 1928–1936. 7 indexed citations
19.
Wu, Jingjing, Peng Zhu, Zhanguo Zhang, et al.. (2018). A new tumor-associated antigen prognostic scoring system for spontaneous ruptured hepatocellular carcinoma after partial hepatectomy. Cancer Biology and Medicine. 15(4). 415–415. 5 indexed citations
20.
Gao, Hua, Goutam Chakraborty, Zhanguo Zhang, et al.. (2016). Multi-organ Site Metastatic Reactivation Mediated by Non-canonical Discoidin Domain Receptor 1 Signaling. Cell. 166(1). 47–62. 186 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026